AlphAIAlphAI — Financial news for AI agents
SEC EDGARMAY 281 min read$GGB

Metz Mauricio sold $24K of GGB

Metz Mauricio sold 5,000 shares of GERDAU S.A. (GGB) at $4.70 on 2026-05-26.

Original reporting
SEC EDGAR · Metz Mauricio
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$GGB
Neutral
medium confidence
Mentioned
$GGB
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GGBNeutralLow
01

Why it matters

An insider sold 5,000 shares at $4.70 on 2026-05-26; the filing notes no pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor for follow-on insider activity, but this single sale provides no new operational or financial information.

03

What to watch

Insider sales are often liquidity-driven and can be non-informational; the article lacks context on compensation, taxes, or broader insider activity trends.

Relevance 3/10Novelty 3/10Timing: filed 2026-05-28, transaction dated 2026-05-26

Background

The article is a SEC Form 4 insider transaction disclosure for Gerdau S.A. (GGB).

Company-level read

Ticker impact

$GGBNeutralMedium confidence
Context

Gerdau S.A. (GGB) disclosed an insider open-market sale of 5,000 shares by Metz Mauricio on 2026-05-26.

Expected impact

Likely limited near-term impact; treat as low-signal unless follow-on filings show sustained selling.

Evidence & confidence

The filing provides transaction size, price, and post-sale holdings, but no accompanying company-specific news, guidance, or legal/operational catalyst.

Market effects

Sector

No sector-level implications are disclosed beyond a single insider transaction.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Absence of a 10b5-1 plan could be interpreted as discretionary selling, which some traders may read as bearish.

Key entities

  • issuer
    GERDAU S.A.

    Company whose insider transaction was reported on SEC Form 4.

  • insider
    Metz Mauricio

    Reporter of the open-market sale transaction.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

GGB insider trading history →

Related articles

OCT 28
$GGBMed

Gerdau (GGB) Q3 2026 Earnings Call Transcript

Gerdau S.A. reported Q3 2026 earnings, highlighting BRL 1.7B free cash flow, BRL 0.34/share dividends, and a solid balance sheet. The company expects to return over BRL 1.85B to shareholders in 2026. North American operations showed strong demand, while Brazil faced seasonal slowdowns and import challenges. The company plans adjustments to improve Brazilian profitability and is awaiting government support on trade and energy policies.

finance.yahoo.com2 min
OCT 27
$GGBMed

What Gerdau (GGB) Said on Its Q3 Earnings Call

Gerdau (GGB) is expanding capacity at its Texas facility, with full production expected by 2027. The company focuses on organic investments, not spin-offs or major acquisitions. Management discussed potential trade impacts on regional margins. In Brazil, Gerdau faces import pressure but plans productivity improvements. The company announced dividends and reduced capital expenditure plans to BRL 4 billion. Net debt to EBITDA is 0.58 times, with a positive outlook from S&P.

finance.yahoo.com2 min
OCT 27
$GGBMedAI 8/10

Gerdau ADR earnings missed, revenue topped estimates

Gerdau ADR (GGB) reported Q3 EPS of $0.159, missing estimates of $0.165, while revenue of $3.75B exceeded expectations. The stock is down 4.23% over 3 months but up 37.28% year-over-year. Analysts revised EPS positively twice in the last 90 days. InvestingPro rates its financial health as good.

investing.com1 min